TB

This document is designed to serve as a handbook, or primer, for NGOs and CSOs that are considering joining the fight against TB. It provides information on TB and how it is prevented, diagnosed, and treated, how TB programs work on the ground, how communities and CSOs can get involved, and special populations that need extra attention. Step-by-step guidance on getting started in addressing TB, pitfalls to avoid, and a list of useful resources are included.

The purpose of this document is to provide operational guidance to NGOs and other CSOs and NTPs or their equivalents in implementing and scaling-up integrated community-based TB prevention, diagnosis, treatment and care using the ENGAGE-TB approach described in the document. The principles are aligned with the Stop TB Strategy and are complementary to existing guidelines for engaging all health care providers (including NGOs) in TB prevention and care as part of a public–private mix.

This pocket-sized card for clinicians provides information on identifying those at risk for TB. The resource also includes content on latent TB infection testing, diagnosis, and treatment in adults. 

The main purpose of this guide is to describe and explain how to design, implement and analyse an inventory study to measure TB under-reporting. The guide also explains how to apply capture-recapture methods to estimate TB incidence, emphasizing the conditions that must be fulfilled for these methods to be used. This guide is intended for use by NTP managers, researchers including epidemiologists and statisticians, and agencies that provide financial and technical support for inventory studies.

In this video, Dr. Caralee Caplan-Shaw and her patients clarify the risks of untreated latent TB infection and motivate your patients to complete treatment.

The handout describes the main characteristics of LTBI and Active TB, as well as their differences. The material also describes what increases the risk for developing Active TB and how to prevent TB from developing. 

The handout describes the main characteristics of LTBI and Active TB, as well as their differences. The material also describes what increases the risk for developing Active TB and how to prevent TB from developing.

This guide is designed to explain the safety and efficacy of bedaquiline. It also describes what you as an activist can do to help ensure access, fair pricing and further research. The guide provides messages that regulatory authorities need to hear to prepare for bedaquiline and other new TB drugs.

World TB Day poster available in 5 languages: Creole, English, French, Portuguese, and Spanish

These stories highlight the personal experiences of several people who were diagnosed and treated for TB disease, as well as the work of TB control professionals. You can share individual stories on social media using the social media graphics included on several of the survivor story pages.